174 related articles for article (PubMed ID: 17266393)
1. The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.
Balls M; Amcoff P; Bremer S; Casati S; Coecke S; Clothier R; Combes R; Corvi R; Curren R; Eskes C; Fentem J; Gribaldo L; Halder M; Hartung T; Hoffmann S; Schectman L; Scott L; Spielmann H; Stokes W; Tice R; Wagner D; Zuang V;
Altern Lab Anim; 2006 Dec; 34(6):603-20. PubMed ID: 17266393
[No Abstract] [Full Text] [Related]
2. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
Hess P; Grune B; Anderson DB; Aune T; Botana LM; Caricato P; van Egmond HP; Halder M; Hall S; Lawrence JF; Moffat C; Poletti R; Richmond J; Rossini GP; Seamer C; Vilageliu JS;
Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
[No Abstract] [Full Text] [Related]
3. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50.
Gennari A; van den Berghe C; Casati S; Castell J; Clemedson C; Coecke S; Colombo A; Curren R; Dal Negro G; Goldberg A; Gosmore C; Hartung T; Langezaal I; Lessigiarska I; Maas W; Mangelsdorf I; Parchment R; Prieto P; Sintes JR; Ryan M; Schmuck G; Stitzel K; Stokes W; Vericat JA; Gribaldo L;
Altern Lab Anim; 2004 Oct; 32(4):437-59. PubMed ID: 15651930
[No Abstract] [Full Text] [Related]
4. The principles of validation and the ECVAM validation process.
Worth AP; Balls M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():15-21. PubMed ID: 12513647
[TBL] [Abstract][Full Text] [Related]
5. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52.
Netzeva TI; Worth A; Aldenberg T; Benigni R; Cronin MT; Gramatica P; Jaworska JS; Kahn S; Klopman G; Marchant CA; Myatt G; Nikolova-Jeliazkova N; Patlewicz GY; Perkins R; Roberts D; Schultz T; Stanton DW; van de Sandt JJ; Tong W; Veith G; Yang C
Altern Lab Anim; 2005 Apr; 33(2):155-73. PubMed ID: 16180989
[No Abstract] [Full Text] [Related]
6. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
[TBL] [Abstract][Full Text] [Related]
7. A modular approach to the ECVAM principles on test validity.
Hartung T; Bremer S; Casati S; Coecke S; Corvi R; Fortaner S; Gribaldo L; Halder M; Hoffmann S; Roi AJ; Prieto P; Sabbioni E; Scott L; Worth A; Zuang V
Altern Lab Anim; 2004 Nov; 32(5):467-72. PubMed ID: 15656771
[TBL] [Abstract][Full Text] [Related]
8. The assessment of repeated dose toxicity in vitro: a proposed approach. The report and recommendations of ECVAM workshop 56.
Prieto P; Baird AW; Blaauboer BJ; Castell Ripoll JV; Corvi R; Dekant W; Dietl P; Gennari A; Gribaldo L; Griffin JL; Hartung T; Heindel JJ; Hoet P; Jennings P; Marocchio L; Noraberg J; Pazos P; Westmoreland C; Wolf A; Wright J; Pfaller W
Altern Lab Anim; 2006 Jun; 34(3):315-41. PubMed ID: 16831063
[No Abstract] [Full Text] [Related]
9. Uncertainty of testing methods--what do we (want to) know?
Paparella M; Daneshian M; Hornek-Gausterer R; Kinzl M; Mauritz I; Mühlegger S
ALTEX; 2013; 30(2):131-44. PubMed ID: 23665803
[TBL] [Abstract][Full Text] [Related]
10. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54.
Coecke S; Ahr H; Blaauboer BJ; Bremer S; Casati S; Castell J; Combes R; Corvi R; Crespi CL; Cunningham ML; Elaut G; Eletti B; Freidig A; Gennari A; Ghersi-Egea JF; Guillouzo A; Hartung T; Hoet P; Ingelman-Sundberg M; Munn S; Janssens W; Ladstetter B; Leahy D; Long A; Meneguz A; Monshouwer M; Morath S; Nagelkerke F; Pelkonen O; Ponti J; Prieto P; Richert L; Sabbioni E; Schaack B; Steiling W; Testai E; Vericat JA; Worth A
Altern Lab Anim; 2006 Feb; 34(1):49-84. PubMed ID: 16522150
[No Abstract] [Full Text] [Related]
11. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
Ceridono M; Tellner P; Bauer D; Barroso J; Alépée N; Corvi R; De Smedt A; Fellows MD; Gibbs NK; Heisler E; Jacobs A; Jirova D; Jones D; Kandárová H; Kasper P; Akunda JK; Krul C; Learn D; Liebsch M; Lynch AM; Muster W; Nakamura K; Nash JF; Pfannenbecker U; Phillips G; Robles C; Rogiers V; Van De Water F; Liminga UW; Vohr HW; Wattrelos O; Woods J; Zuang V; Kreysa J; Wilcox P
Regul Toxicol Pharmacol; 2012 Aug; 63(3):480-8. PubMed ID: 22687423
[TBL] [Abstract][Full Text] [Related]
12. Novel advanced in vitro methods for long-term toxicity testing: the report and recommendations of ECVAM workshop 45. European Centre for the Validation of Alternative Methods.
Pfaller W; Balls M; Clothier R; Coecke S; Dierickx P; Ekwall B; Hanley BA; Hartung T; Prieto P; Ryan MP; Schmuck G; Sladowski D; Vericat JA; Wendel A; Wolf A; Zimmer J
Altern Lab Anim; 2001; 29(4):393-426. PubMed ID: 11506637
[No Abstract] [Full Text] [Related]
13. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods.
Genschow E; Spielmann H; Scholz G; Seiler A; Brown N; Piersma A; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Becker K
Altern Lab Anim; 2002; 30(2):151-76. PubMed ID: 11971753
[TBL] [Abstract][Full Text] [Related]
14. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
Combes RD
Altern Lab Anim; 2002 Dec; 30 Suppl 2():151-65. PubMed ID: 12513668
[TBL] [Abstract][Full Text] [Related]
15. FRAME and the validation process.
Balls M; Clothier R
Altern Lab Anim; 2009 Dec; 37(6):631-40. PubMed ID: 20104999
[TBL] [Abstract][Full Text] [Related]
16. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
Spielmann H; Liebsch M
Toxicol In Vitro; 2001; 15(4-5):585-90. PubMed ID: 11566595
[TBL] [Abstract][Full Text] [Related]
17. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods.
Brown NA
Altern Lab Anim; 2002; 30(2):177-98. PubMed ID: 11971754
[TBL] [Abstract][Full Text] [Related]
18. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
Stokes WS; Schechtman LM; Hill RN
Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
[TBL] [Abstract][Full Text] [Related]
19. Developing alternatives to systemic toxicity testing approaches.
von Aulock S
ALTEX; 2012; 29(1):1. PubMed ID: 22408846
[No Abstract] [Full Text] [Related]
20. Peer review of validation studies: an assessment of the role of the OECD by reference to the validation of the uterotrophic assay for endocrine disruptors.
Combes RD
Altern Lab Anim; 2004 Jun; 32(2):111-7. PubMed ID: 15601239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
